• Sections
  • Newsletters
  • Podcasts
  • Support TPM
  • Shop Merch
  • Site Info
  • About
  • Sections
  • Editors' Blog
  • News
  • Live Blog
  • Cafe
  • Muckraker
  • Morning Memo
  • Where Things Stand
  • The Weekender
  • Features
  • Support TPM
  • Memberships
  • The TPM Journalism Fund
  • Site Info
  • FAQ
  • Contact
  • Advertise
  • Terms
  • Privacy
  • Site Status
  • About
  • About TPM
  • Mission
  • Masthead
  • Financials
  • Careers
  • Pitch Us
Follow TPM
© 2025 TPM MEDIA LLC. ALL RIGHTS RESERVED.
Talking Points Memo Logo
Send Tips TPM 25th Anniversary Badge
Moncef Slaoui
Neal Browning receives a shot in the first-stage safety study clinical trial of a potential vaccine for the COVID-19 coronavirus, Monday, March 16, 2020, at the Kaiser Permanente Washington Health Research Institute in Seattle. Browning is the second patient to receive the shot in the study. (AP Photo/Ted S. Warren) Neal Browning receives a shot in the first-stage safety study clinical trial of a potential vaccine for the COVID-19 coronavirus, Monday, March 16, 2020, at the Kaiser Permanente Washington Health Research Institute in Seattle. Browning is the second patient to receive the shot in the study. (AP Photo/Ted S. Warren)
FDA Says Suggestion To Halve Moderna Vaccine ‘Not Rooted’ In Available Science
By Zoe Richards
01.05.21 | 9:05 am
Chief OWS Adviser: ‘I Literally Don’t Know’ What Trump Is Talking About On Vaccine Order
By Zoe Richards
12.08.20 | 10:51 am
WH COVID Officials Dispute Biden’s Claim Of ‘No Detailed Plan’ On Vaccine Rollout
By Summer Concepcion
12.06.20 | 3:21 pm
WH Vaccine Czar Predicts Herd Immunity From COVID Vaccine By May. Fauci Thinks Not.
By Summer Concepcion
11.22.20 | 2:28 pm
Next →
Talking Points Memo
© 2025 TPM MEDIA LLC.
Masthead Contact Privacy Policy
  • About
  • Memberships
  • Careers
  • Advertise
  • Site Status
  • FAQ
  • Newsletters
  • Pitch Us
  • Terms of Use
  • CCPA Notice